Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial

BACKGROUND: COVID-19 progression is associated with an increased risk of arterial and venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the risk of thromboembolism in hospitalised patients with COVID-19, but a benefit of routine anticoagulation has not been demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Avezum, Álvaro, Oliveira Junior, Haliton Alves, Neves, Precil Diego M.M., Alves, Lucas Bassolli O., Cavalcanti, Alexandre B., Rosa, Regis G., Veiga, Viviane C., Azevedo, Luciano C.P., Zimmermann, Sérgio Luiz, Silvestre, Odilson Marcos, Seabra Prudente, Raphael Cruz, Morales Kormann, Adrian Paulo, Moreira, Frederico Rafael, Boszczowski, Icaro, de Brito Sobrinho, Edgar, da Silva e Souza, André, Seligman, Renato, de Souza Paolino, Bruno, Razuk, Alvaro, Diogenes de Magalhaes Feitosa, Audes, Monteiro Belmonte, Pedro Luiz, Freitas das Neves Gonçalves, Priscila, Hernandes, Mauro Esteves, Fagundes, Ariovaldo Leal, Sarmet Esteves, José Maria, Tognon, Alexandre Pereira, Eikelboom, John, Berwanger, Otávio, Lopes, Renato D., Oliveira, Gustavo B.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194052/
https://www.ncbi.nlm.nih.gov/pubmed/37223666
http://dx.doi.org/10.1016/j.eclinm.2023.102004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194052/
https://www.ncbi.nlm.nih.gov/pubmed/37223666
http://dx.doi.org/10.1016/j.eclinm.2023.102004

Ejemplares similares